Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
08-Jun-2022
North America
Market Research
PD27-01-00-00-00
HC03548-NA-MT_26593
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring
of biopharmaceutical products for COVID-19 and next-generation biologics has significantly increased the demand for aseptic fill-and-finish capacity and capabilities to meet the demand from various regions. All these factors have made sterile injectable drug product services outsourcing the most lucrative opportunity for contract development and manufacturing companies (CDMO)s. The sterile injectable outsourcing market is set to expand at a CAGR of 9.4%% from 2021 to 2026.
Accelerated project timeframes have prompted CDMOs to review their approach and consider strategies that support greater agility in fill-and-finish operations. The development and manufacturing of high-potency small molecules, less-soluble drugs, and targeted small molecules have allowed small-molecule CDMOs to showcase their capabilities and expertise to pharmaceutical partners. Similarly, biologic manufacturing requires advanced manufacturing/quality control technologies, equipment and skill sets. Biopharma companies and innovative biotech players are increasingly outsourcing process development and manufacturing to CDMOs that possess excellent technologies and equipment.
In this report, Frost & Sullivan offers:
• Insights through market forecasts
• Analysis by segment: small-molecule FDF and biologic drug product
• Market trends, drivers, and restraints
• CDMOs’ investment and expansion into injectable capacity
• Opportunities that stakeholders can pursue
Author: Surbhi Gupta
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Sterile Injectables Outsourcing
Growth Opportunities Fuel the Growth Pipeline Engine™
Key Takeaways
Scope of Analysis
Forecast Framework—CDMO
Forecast Methodology—Sterile Injectable Outsourcing
Forecast Assumptions
Key Growth Metrics
Growth Drivers
Growth Restraints
Revenue Forecast
Revenue Forecast by Product Type
Revenue Forecast Analysis
Therapeutic Area Overview
Therapeutic Area Overview (continued)
Supply Chain and the Evolving Role of Vendors
Recent Trends Driving Collaborations & Expansions
Recent Trends Driving Collaborations & Expansions (continued)
Capability Overview of Select CDMOs
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—US (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—Europe
CDMO Acquisitions and Sterile Injectable Capacity Expansion—Europe (continued)
CDMO Acquisitions and Sterile Injectable Capacity Expansion—APAC
Smartification of Injectable Delivery Device
Growth Opportunity 1: Flexible and Modular Aseptic Fill-and-Finish Capabilities
Growth Opportunity 1: Flexible and Modular Aseptic Fill-and-Finish Capabilities (continued)
Growth Opportunity 2: Strategic Partnerships that Provide Integrated Injectable Drug Product and Device Service
Growth Opportunity 2: Strategic Partnerships to Provide Integrated Injectable Drug Product and Device Service (continued)
Growth Opportunity 3: Cold-chain Capabilities that Support Next-gen Biologics
Growth Opportunity 3: Cold-chain Capabilities that Support Next-gen Biologics (continued)
List of Exhibits
Legal Disclaimer
- Sterile Injectable Outsourcing: Key Growth Metrics, Global, 2021
- Sterile Injectable Outsourcing: Growth Drivers, Global, 2022–2026
- Sterile Injectable Outsourcing: Growth Restraints, Global, 2022–2026
- Sterile Injectable Outsourcing: Revenue Forecast, Global, 2020–2026
- Sterile Injectable Outsourcing: Revenue Forecast by Product Type, Global, 2020–2026
- Sterile Injectable Outsourcing: Revenue Share by Therapeutic Area, Global, 2021 and 2026
- Sterile Injectable Outsourcing: Revenue Share by Technology Type, Global, 2021 and 2026
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.